Cerebral angiography is a medical imaging technique used to visualize the blood vessels in the brain and neck and diagnose medical conditions such as aneurysms, arteriovenous malformations, carotid artery stenosis, cerebral vasospasm, and others. Cerebral angiography provides detailed pictures of the blood vessels supplying the brain which helps physicians accurately diagnose and treat several neurological disorders without surgery.
The global Cerebral Angiography Market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing demand for minimally invasive procedures: Minimally invasive procedures such as cerebral angiography help to diagnose and treat medical conditions effectively while minimizing procedural risks, pain, recovery time and costs compared to open surgeries. Growing preference for minimally invasive options among patients and physicians alike has been a major factor driving the adoption of cerebral angiography. Technological advancements enabling high resolution 3D imaging and navigation have further increased the applicability of cerebral angiography, thus propelling the market growth.
SWOT Analysis
Strength: Cerebral angiography provides a minimally invasive method to visualize blood vessels in the brain and detect abnormalities. It helps in accurate diagnosis and treatment planning for conditions like aneurysms, vascular malformations, and more.
Weakness: Cerebral angiography involves exposure to radiation and iodinated contrast agents which may lead to potential side effects. It also requires specialized equipment and trained healthcare professionals limiting its widespread adoption.
Opportunity: Rising geriatric population increasing the risk of cerebrovascular diseases and growing awareness about early disease detection offer significant growth potential. Technological advancements in less invasive angiography systems also expand the market scope.
Threats: Availability of alternative imaging modalities like CT angiography and MRI angiography poses competition. Stringent regulatory approvals and reimbursement policies pose challenges.
Key Takeaways
The Global Cerebral Angiography Market Size is expected to witness high growth at a CAGR of 6.1% during the forecast period of 2023 to 2030. Regional analysis – North America dominates the global market and is expected to retain its position aided by high healthcare spending and developing healthcare infrastructure. Factors such as growing prevalence of cerebrovascular diseases, ongoing clinical research, and rising demand for minimal invasive procedures are anticipated to drive the North American market.
Key players – Key players operating in the cerebral angiography market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, and Cook Medical LLC. These companies are focusing on new product launches and enhancing their existing portfolio through mergers & acquisitions to strengthen market presence.
The global cerebral angiography market is expected to witness high growth. Regional analysis comprises – The North America cerebral angiography market dominates the global landscape and is expected to witness highest growth during the forecast period supported by growing geriatric population, demand for minimally invasive surgeries, and availability of advanced healthcare facilities.
Key players operating in the cerebral angiography market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, and Cook Medical LLC. These companies are focusing on product innovations for non-invasive angiography systems through extensive R&D investments which is anticipated to strengthen their market position
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it